Highlights Orthocell Limited

Equities

OCC

AU000000OCC6

Delayed Australian S.E. Other stock markets 23:26:36 2024-06-25 EDT			5-day change	1st Jan Change
0.365 ^AUD	+1.39%		-2.67%	-10.98%

06-11	Orthocell Files Application With Therapeutic Goods Administration for Tendon Repair Product; Shares Rise 3%	MT
05-14	Orthocell's Striate+ Dental Membrane Product Achieves 98.6% Success Rate in Post-Market Clinical Study; Shares Up 3%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orthocell Files Application With Therapeutic Goods Administration for Tendon Repair Product; Shares Rise 3%	06-10	MT
Orthocell's Striate+ Dental Membrane Product Achieves 98.6% Success Rate in Post-Market Clinical Study; Shares Up 3%	05-13	MT
Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3%	04-14	MT
Orthocell Revenue Soars 19% to AU$1.61 Million in Q1	04-08	MT
Orthocell Completes First Stage of Remplir US Market Authorization Study	03-24	MT
Orthocell Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-22	CI
Orthocell Submits Regulatory Application for Remplir in Singapore	02-12	MT
Orthocell Limited Provides Commercial Revenue Guidance for the Full Year 2023	23-10-24	CI
Orthocell Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
Orthocell Secures Over AU$3 Million R&D Tax Rebate	23-06-20	MT
Orthocell Begins Comparator Study for Product Marketing Initiatives	23-04-17	MT
Orthocell Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-28	CI
Orthocell's Nerve Repair Product Joins Australian Prosthesis Reimbursement List	22-10-31	MT
Orthocell Limited's Rotator Cuff Study Success with Cross-Over Patients	22-09-28	CI
Orthocell Limited Announces the First Purchase Orders of CelGro Medical Devices Striate (For Dental Bone and Tissue Regeneration) and Remplir	22-09-26	CI
Orthocell Appoints Exclusive Distributor of Remplir Device	22-09-07	MT
Orthocell Limited Appoints Device Technologies as Its Exclusive Distributor of RemplirTM	22-09-06	CI
Orthocell Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-30	CI
Orthocell Limited Announces Update on Striate Global License and Distribution Agreement with Biohorizons Implant Systems, Inc	22-07-20	CI
Orthocell Signs Striate+Tm Global Exclusive License and Manufacturing Agreement with Biohorizons	22-06-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Orthocell Limited

Equities

OCC

AU000000OCC6

Highlights

Filters